CA2865355C - Nasal delivery devices - Google Patents

Nasal delivery devices Download PDF

Info

Publication number
CA2865355C
CA2865355C CA2865355A CA2865355A CA2865355C CA 2865355 C CA2865355 C CA 2865355C CA 2865355 A CA2865355 A CA 2865355A CA 2865355 A CA2865355 A CA 2865355A CA 2865355 C CA2865355 C CA 2865355C
Authority
CA
Canada
Prior art keywords
subject
housing
nasal
delivery device
actuation member
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2865355A
Other languages
English (en)
French (fr)
Other versions
CA2865355A1 (en
Inventor
Per Gisle Djupesland
Kate DUDGEON
Joseph Gordon
Mark Guarraia
Michael Leclerc
Ramy A. Mahmoud
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Optinose Inc
Original Assignee
Optinose AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Optinose AS filed Critical Optinose AS
Publication of CA2865355A1 publication Critical patent/CA2865355A1/en
Application granted granted Critical
Publication of CA2865355C publication Critical patent/CA2865355C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/08Inhaling devices inserted into the nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0001Details of inhalators; Constructional features thereof
    • A61M15/0021Mouthpieces therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/04Liquids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/06Solids
    • A61M2202/064Powder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/58Means for facilitating use, e.g. by people with impaired vision
    • A61M2205/586Ergonomic details therefor, e.g. specific ergonomics for left or right-handed users
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00Anatomical parts of the body
    • A61M2210/06Head
    • A61M2210/0618Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00Anatomical parts of the body
    • A61M2210/06Head
    • A61M2210/0625Mouth

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Otolaryngology (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicinal Preparation (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
CA2865355A 2012-02-24 2013-02-25 Nasal delivery devices Active CA2865355C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261603089P 2012-02-24 2012-02-24
US61/603,089 2012-02-24
PCT/EP2013/053748 WO2013124493A1 (en) 2012-02-24 2013-02-25 Nasal delivery devices

Publications (2)

Publication Number Publication Date
CA2865355A1 CA2865355A1 (en) 2013-08-29
CA2865355C true CA2865355C (en) 2021-02-16

Family

ID=47915159

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2865355A Active CA2865355C (en) 2012-02-24 2013-02-25 Nasal delivery devices

Country Status (12)

Country Link
US (1) US10179216B2 (instruction)
EP (1) EP2817053B1 (instruction)
JP (1) JP6382723B2 (instruction)
CN (1) CN104428024B (instruction)
CA (1) CA2865355C (instruction)
DK (1) DK2817053T3 (instruction)
ES (1) ES2683865T3 (instruction)
IN (1) IN2014DN07610A (instruction)
MX (1) MX358062B (instruction)
PL (1) PL2817053T3 (instruction)
RU (1) RU2644293C2 (instruction)
WO (1) WO2013124493A1 (instruction)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0215270D0 (en) 2002-07-02 2002-08-14 Optinose As Nasal devices
GB0311570D0 (en) 2003-05-20 2003-06-25 Optinose As Delivery device and method
GB0319119D0 (en) 2003-08-14 2003-09-17 Optinose As Delivery devices
GB0320171D0 (en) 2003-08-28 2003-10-01 Optinose As Delivery devices
GB0420513D0 (en) 2004-09-15 2004-10-20 Optinose As Powder delivery devices
GB0503738D0 (en) 2005-02-23 2005-03-30 Optinose As Powder delivery devices
CA2642608C (en) 2006-01-19 2018-05-29 Optinose As Nasal administration
GB0602980D0 (en) 2006-02-14 2006-03-29 Optinose As Delivery device and method
GB0604444D0 (en) 2006-03-06 2006-04-12 Optinose As Nasal devices
GB0605799D0 (en) 2006-03-23 2006-05-03 Optinose As Nasal delivery devices
GB2438834A (en) 2006-06-08 2007-12-12 Optinose As Intranasal protein administration
GB2440316A (en) 2006-07-25 2008-01-30 Optinose As Nasal inhaler with scrubber
GB0623731D0 (en) 2006-11-28 2007-01-10 Optinose As Delivery device
GB0623728D0 (en) 2006-11-28 2007-01-10 Optinose As Delivery devices
GB0623732D0 (en) 2006-11-28 2007-01-10 Optinose As Powder delivery devices
GB2448183A (en) 2007-04-05 2008-10-08 Optinose As Nasal powder delivery device
GB2448193A (en) 2007-04-05 2008-10-08 Optinose As Nasal delivery device
GB0719299D0 (en) 2007-10-03 2007-11-14 Optinose As Nasal delivery devices
GB201015371D0 (en) 2010-09-14 2010-10-27 Optinose As Nasal delivery
US9949923B2 (en) 2011-03-15 2018-04-24 Optinose As Nasal delivery
EP2817053B1 (en) 2012-02-24 2018-05-30 Optinose AS Nasal delivery devices
IN2014DN07611A (instruction) 2012-02-24 2015-05-15 Optinose As
KR20150004327A (ko) 2012-02-24 2015-01-12 옵티노즈 에이에스 경비 투여 장치
US11554229B2 (en) 2013-03-26 2023-01-17 OptiNose Inc. Nasal administration
USD761951S1 (en) 2013-05-23 2016-07-19 Optinose As Nosepiece unit
EP2868334B1 (de) 2013-11-05 2017-01-11 Benedict Gerber Nasendusche
SG11201703792XA (en) 2014-11-19 2017-06-29 Optinose As Intranasal administration
MX2022009050A (es) 2020-01-22 2022-10-27 Seelos Therapeutics Inc Reduccion de los efectos secundarios de los antagonistas de nmda.
KR20220151265A (ko) 2021-05-06 2022-11-15 김대황 비강 약물 투여 장치 및 방법
US20240261236A1 (en) 2021-05-14 2024-08-08 Seelos Therapeutics, Inc. Methods of using nmda receptor antagonists
US20230285278A1 (en) * 2022-03-06 2023-09-14 Optinose, Inc. Methods for treating chronic rhinosinusitis
CN114602046A (zh) * 2022-05-10 2022-06-10 纳索菲德(上海)制药技术有限公司 向鼻腔嗅区递送药液的装置及其使用方法

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US605436A (en) 1898-06-07 Inhaler
US642748A (en) 1899-02-23 1900-02-06 Arthur Manners Inhaler.
US746749A (en) 1903-03-18 1903-12-15 George E Seidel Nasal medicator.
BR9606838A (pt) 1995-01-23 1999-11-30 Direct Haler A S Inalador
US5797392C1 (en) 1996-01-22 2001-01-09 Direct Haler As Inhaler
DE69825995T2 (de) 1997-05-27 2005-09-08 Direct-Haler A/S Inhalator für pulverförmige medikamente
GB0114272D0 (en) 2001-06-12 2001-08-01 Optinose As Nasal delivery device
ES2600357T3 (es) 1999-03-03 2017-02-08 Optinose As Dispositivo de administración nasal
GB0121568D0 (en) 2001-09-06 2001-10-24 Optinose As Nasal delivery device
US6644305B2 (en) * 2000-04-14 2003-11-11 Trudell Medical International Nasal inhaler
GB0015309D0 (en) 2000-06-21 2000-08-16 Djupesland Per G Apparatus
ZA200306564B (en) 2001-02-26 2004-10-15 Optinose As Nasal devices.
GB0207422D0 (en) 2002-03-28 2002-05-08 Optinose As Nasal devices
GB0207817D0 (en) 2002-04-04 2002-05-15 Optinose As Nasal devices
GB0209494D0 (en) 2002-04-25 2002-06-05 Optinose As Nasal devices
GB0215270D0 (en) 2002-07-02 2002-08-14 Optinose As Nasal devices
GB0215904D0 (en) 2002-07-09 2002-08-21 Team Holdings Uk Ltd Drug delivery system and method
GB0300008D0 (en) 2003-01-02 2003-02-05 Optinose As Delivery devices
GB0311570D0 (en) 2003-05-20 2003-06-25 Optinose As Delivery device and method
GB0319119D0 (en) 2003-08-14 2003-09-17 Optinose As Delivery devices
GB0320171D0 (en) 2003-08-28 2003-10-01 Optinose As Delivery devices
USD530815S1 (en) 2004-03-19 2006-10-24 Optinose As Nasal delivery device
GB0420513D0 (en) 2004-09-15 2004-10-20 Optinose As Powder delivery devices
GB0503738D0 (en) 2005-02-23 2005-03-30 Optinose As Powder delivery devices
CA2642608C (en) 2006-01-19 2018-05-29 Optinose As Nasal administration
GB0602980D0 (en) 2006-02-14 2006-03-29 Optinose As Delivery device and method
GB2434990B (en) 2006-02-14 2010-12-01 Optinose As Delivery device and method
GB0604319D0 (en) 2006-03-03 2006-04-12 Optinose As Nasal delivery
GB0604444D0 (en) 2006-03-06 2006-04-12 Optinose As Nasal devices
GB0605799D0 (en) 2006-03-23 2006-05-03 Optinose As Nasal delivery devices
GB2437488A (en) 2006-04-25 2007-10-31 Optinose As Pharmaceutical oily formulation for nasal or buccal administration
GB2438834A (en) 2006-06-08 2007-12-12 Optinose As Intranasal protein administration
GB2440316A (en) 2006-07-25 2008-01-30 Optinose As Nasal inhaler with scrubber
WO2008067254A2 (en) * 2006-11-27 2008-06-05 Abbott Respiratory Llc Nasal drug delivery device and method
GB0623732D0 (en) 2006-11-28 2007-01-10 Optinose As Powder delivery devices
GB0623728D0 (en) 2006-11-28 2007-01-10 Optinose As Delivery devices
GB0623731D0 (en) 2006-11-28 2007-01-10 Optinose As Delivery device
CN200994915Y (zh) 2006-12-27 2007-12-26 游世规 一种鼻腔清洗器
WO2008122018A1 (en) * 2007-04-02 2008-10-09 Abbott Respiratory Llc Breath actuated nasal pump
GB2448183A (en) 2007-04-05 2008-10-08 Optinose As Nasal powder delivery device
GB2448193A (en) 2007-04-05 2008-10-08 Optinose As Nasal delivery device
GB0719299D0 (en) 2007-10-03 2007-11-14 Optinose As Nasal delivery devices
GB2471973B (en) 2007-10-03 2012-03-14 Optinose As Nasal delivery devices
WO2010029441A2 (en) 2008-09-15 2010-03-18 Optinose As Nasal delivery
EP2210580B1 (fr) * 2009-01-27 2019-03-06 Laboratoire de la Mer Canule pour l'administration d'une solution fluide dans une narine
CA3002216C (en) 2010-06-04 2020-04-14 Creare, Incorporated Nasal aerosol delivery system
GB201015371D0 (en) 2010-09-14 2010-10-27 Optinose As Nasal delivery
US9949923B2 (en) 2011-03-15 2018-04-24 Optinose As Nasal delivery
IN2014DN07611A (instruction) 2012-02-24 2015-05-15 Optinose As
EP2817053B1 (en) 2012-02-24 2018-05-30 Optinose AS Nasal delivery devices
KR20150004327A (ko) 2012-02-24 2015-01-12 옵티노즈 에이에스 경비 투여 장치
RU2015145449A (ru) 2013-03-26 2017-05-03 Оптиноуз Ас Интраназальное введение
US11554229B2 (en) 2013-03-26 2023-01-17 OptiNose Inc. Nasal administration
USD723156S1 (en) 2013-05-23 2015-02-24 Optinose As Nasal delivery device
USD725769S1 (en) 2013-05-23 2015-03-31 Optinose As Nasal delivery device

Also Published As

Publication number Publication date
RU2014138492A (ru) 2016-04-10
MX358062B (es) 2018-08-03
US10179216B2 (en) 2019-01-15
EP2817053B1 (en) 2018-05-30
EP2817053A1 (en) 2014-12-31
WO2013124493A1 (en) 2013-08-29
PL2817053T3 (pl) 2019-01-31
US20150246194A1 (en) 2015-09-03
CN104428024A (zh) 2015-03-18
IN2014DN07610A (instruction) 2015-05-15
ES2683865T3 (es) 2018-09-28
MX2014010146A (es) 2015-10-22
JP6382723B2 (ja) 2018-08-29
DK2817053T3 (en) 2018-08-13
HK1207010A1 (en) 2016-01-22
RU2644293C2 (ru) 2018-02-08
CA2865355A1 (en) 2013-08-29
JP2015507991A (ja) 2015-03-16
CN104428024B (zh) 2018-06-01

Similar Documents

Publication Publication Date Title
CA2865355C (en) Nasal delivery devices
US20250235642A1 (en) Nasal delivery devices
US20240316297A1 (en) Nasal delivery devices
EP1988953B1 (en) Delivery device
HK1207010B (en) Nasal delivery devices
HK1205699B (en) Nasal delivery devices

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20180220